Role of Bax and pH in Death by Cytokine Withdrawal

描述（由申请人提供）： 调节细胞凋亡的基因产物在癌症中经常发生突变。 通常，凋亡性细胞死亡是淋巴细胞发育和维持的重要部分，其中存活或营养信号（例如细胞因子）的丧失是死亡的主要触发因素。 因此，阐明新的调节蛋白和细胞因子撤退过程中的代谢变化是至关重要的细胞死亡过程的理解，更重要的是发现新的组件在癌变过程中突变。 为此，已证明在烟碱依赖性细胞系中通过细胞因子撤出诱导的细胞凋亡的研究是成功的。 在最初的研究中，细胞因子信号传导的丧失导致细胞溶质的快速和短暂的碱化，由pH调节蛋白、钠/氢交换剂1（NHE 1）和p38 MAP激酶（MAPK）介导。 这种pH值的升高被认为是导致促凋亡蛋白Bax的线粒体易位，从而导致细胞死亡。 作为第一个目标，提出了一个两部分的研究，严格检验的假设，碱性pH值导致Bax的运动，线粒体中的中和带电的氨基酸在末端。 首先，将评价对Bax的非pH依赖性修饰或间接pH效应。 第二，将制备一系列Bax突变体以靶向所提出的pH敏感位点，并在凋亡和非凋亡条件下测试线粒体易位。 预期的结果是证明Bax是一种pH响应蛋白。 在第二个目标中，将评估pH升高的介质NHE 1在细胞凋亡期间的功能。 先前的工作确定了NHE 1上的四个候选位点作为p38 MAPK磷酸化的靶点。 这些位点的重要性将通过以下方法确定：首先，使用突变的GST-NHE 1融合蛋白作为磷酸化底物进行p38 MAPK激酶测定，其次，在凋亡和非凋亡条件下在NHE 1缺陷细胞系中表达全长NHE 1突变蛋白。 预期表达突变体NHE 1的细胞不会碱化，Bax不会易位，死亡将被抑制。 未来的目标包括通过NHE分析碱化机制和阐述Bax在线粒体损伤中的作用。 这项工作将是一个学术研究计划的基础，作为一个终身跟踪的教师，从pH介导的凋亡变化的独特视角识别和应用癌症中突变的新型凋亡因子。

DESCRIPTION (provided by applicant): Gene products that regulate apoptosis are frequently mutated in cancer. Normally, apoptotic cell death is an essential part of lymphocyte development and maintenance, with the loss of a survival or trophic signal, such as a cytokine, as principal trigger for death. Hence, elucidation of novel regulatory proteins and metabolic changes during cytokine withdrawal is of vital importance for the understanding of the cell death process and more so for discovering new components mutated during carcinogenesis. To this end, the study of apoptosis induced by cytokine withdrawal in cytokine-dependent cell lines has proven successful. In initial studies, loss of cytokine signaling led to a rapid and transient alkalinization of the cytosol, mediated by the pH regulating protein, the sodium/hydrogen exchanger1 (NHE1) and p38 MAP kinase (MAPK). This rise in pH is proposed to cause the mitochondrial translocation of the pro-apoptotic protein, Bax, resulting in cell death. As the first aim, a two-part study is proposed to rigorously test the hypothesis that alkaline pH causes the movement of Bax to mitochondria by neutralizing charged amino acids in the termini. First, pH-independent modifications or indirect pH effects on Bax will be evaluated. Second, a series of Bax mutants will be made to target proposed pH sensitive sites and tested for mitochondrial translocation under apoptotic and non-apoptotic conditions. The expected outcome is to prove that Bax is a pH-responsive protein. In the second aim, the mediator of the pH rise, NHE1, will be evaluated for function during apoptosis. Previous work identified four candidate sites on NHE1 as targets for p38 MAPK phosphorylation. The importance of these sites will be determined by, first, performing p38 MAPK kinase assays using mutated GST-NHE1 fusion proteins as substrates for phosphorylation, and second, expressing full-length NHE1 mutant proteins in an NHE1-deficient cell line under apoptotic and non-apoptotic conditions. It is expected that mutant NHE1 expressing cells will not alkalinize, Bax will not translocate and death will be inhibited. Future aims include analysis of the alkalinization mechanism through NHE and elaboration of the role of Bax in mitochondrial damage. This work will be the foundation of an academic research program, as a tenure-tracked faculty, for the identification and application of novel apoptotic factors mutated in cancer from the unique perspective of pH-mediated apoptotic changes.